Last update at 2025-04-14T16:52:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Health Insurance Providers Stocks Q4 Teardown: Humana (NYSE:HUM) Vs The Rest
Thu 10 Apr 25, 09:08 AMTuesday's session: top gainers and losers in the S&P500 index
Tue 08 Apr 25, 09:05 PMWhich S&P500 stocks are gapping on Tuesday?
Tue 08 Apr 25, 04:35 PMCigna Group Stock Sees RS Rating Jump To 86
Fri 04 Apr 25, 08:17 PMSpotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4
Thu 03 Apr 25, 09:10 AMQ4 Rundown: Elevance Health (NYSE:ELV) Vs Other Health Insurance Providers Stocks
Wed 02 Apr 25, 09:04 AMMolina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?
Tue 01 Apr 25, 09:03 AMMolina Healthcare, Inc. (MOH) Rallies Despite Tariff Worries – Jim Cramer Weighs In
Sat 29 Mar 25, 08:17 PMHealth Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)
Thu 27 Mar 25, 09:12 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 1063.00M | 875.00M | 961.00M | 972.00M | 999.00M |
Minority interest | - | - | - | - | - |
Net income | 792.00M | 659.00M | 673.00M | 737.00M | 707.00M |
Selling general administrative | 2311.00M | 2068.00M | 1480.00M | 1296.00M | 1333.00M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 3926.00M | 3280.00M | 2677.00M | 2435.00M | 2624.00M |
Reconciled depreciation | 176.00M | 131.00M | 88.00M | 89.00M | 127.00M |
Ebit | 1173.00M | 1020.00M | 1078.00M | 1044.00M | 1175.00M |
Ebitda | 1557.00M | 1126.00M | 1151.00M | 1154.00M | 1302.00M |
Depreciation and amortization | 384.00M | 106.00M | 73.00M | 110.00M | 127.00M |
Non operating income net other | - | -25.00000M | -15.00000M | 15.00M | -17.00000M |
Operating income | 1173.00M | 1020.00M | 1078.00M | 1044.00M | 1131.00M |
Other operating expenses | 30593.00M | 26751.00M | 18345.00M | 15779.00M | 17698.00M |
Interest expense | 110.00M | 120.00M | 102.00M | 87.00M | 115.00M |
Tax provision | 271.00M | 216.00M | 288.00M | 235.00M | 292.00M |
Interest income | 110.00M | 120.00M | 102.00M | 87.00M | 115.00M |
Net interest income | -110.00000M | -120.00000M | -102.00000M | -87.00000M | -115.00000M |
Extraordinary items | - | - | - | - | - |
Non recurring | 208.00M | - | - | 6.00M | 46.00M |
Other items | - | - | - | - | - |
Income tax expense | 271.00M | 216.00M | 288.00M | 235.00M | 292.00M |
Total revenue | 31974.00M | 27771.00M | 19423.00M | 16829.00M | 18890.00M |
Total operating expenses | 2545.00M | 2260.00M | 1599.00M | 1385.00M | 1432.00M |
Cost of revenue | 28048.00M | 24491.00M | 16746.00M | 14394.00M | 16266.00M |
Total other income expense net | -110.00000M | -145.00000M | -117.00000M | -72.00000M | -78.00000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 792.00M | 659.00M | 673.00M | 737.00M | 1291.00M |
Net income applicable to common shares | 792.00M | 659.00M | 673.00M | 737.00M | 707.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 12314.00M | 12209.00M | 9532.00M | 6787.00M | 7154.00M |
Intangible assets | 275.00M | 270.00M | 249.00M | 29.00M | 47.00M |
Earning assets | - | - | - | - | - |
Other current assets | 277.00M | 3449.00M | 2050.00M | 2109.00M | 625.00M |
Total liab | 9350.00M | 9579.00M | 7436.00M | 4827.00M | 5507.00M |
Total stockholder equity | 2964.00M | 2630.00M | 2096.00M | 1960.00M | 1647.00M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 5607.00M | 5835.00M | 1253.00M | 2547.00M | 3404.00M |
Common stock | 0.06M | 0.06M | 0.06M | 0.06M | 0.00000M |
Capital stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Retained earnings | 2796.00M | 2399.00M | 1860.00M | 1781.00M | 1012.00M |
Other liab | 27.00M | 140.00M | 77.00M | 42.00M | 44.00M |
Good will | 1115.00M | 982.00M | 692.00M | 143.00M | 143.00M |
Other assets | 581.00M | 497.00M | 324.00M | 198.00M | 261.00M |
Cash | 4006.00M | 4438.00M | 4154.00M | 2452.00M | 2826.00M |
Cash and equivalents | 4006.00M | 4438.00M | 4154.00M | 2452.00M | 2826.00M |
Total current liabilities | 6855.00M | 7047.00M | 4965.00M | 3269.00M | 4246.00M |
Current deferred revenue | 359.00M | 370.00M | 375.00M | 249.00M | 211.00M |
Net debt | -1615.00000M | -2046.00000M | -1802.00000M | -966.00000M | -1368.00000M |
Short term debt | 0.00000M | 0.00000M | 2696.00M | 18.00M | 241.00M |
Short long term debt | - | - | - | 18.00M | 240.00M |
Short long term debt total | 2391.00M | 2392.00M | 2352.00M | 1486.00M | 1458.00M |
Other stockholder equity | 328.00M | 236.00M | 199.00M | 175.00M | 643.00M |
Property plant equipment | 259.00M | 396.00M | 372.00M | 380.00M | 241.00M |
Total current assets | 10084.00M | 10064.00M | 7876.00M | 5967.00M | 6462.00M |
Long term investments | - | - | - | 79.00M | 120.00M |
Net tangible assets | 1574.00M | 1378.00M | 1155.00M | 1788.00M | 1457.00M |
Short term investments | 3499.00M | 3202.00M | 1875.00M | 1946.00M | 1681.00M |
Net receivables | 2302.00M | 2177.00M | 1672.00M | 1406.00M | 1330.00M |
Long term debt | 2176.00M | 2173.00M | 2127.00M | 1237.00M | 1020.00M |
Inventory | - | -3202.00000M | -1875.00000M | -1946.00000M | - |
Accounts payable | 889.00M | 842.00M | 641.00M | 455.00M | 390.00M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -160.00000M | -5.00000M | 37.00M | 4.00M | -8.00000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 2796.00M | 2399.00M | 1860.00M | 1781.00M | 1012.00M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 361.00M | 391.00M | 255.00M | 105.00M | 24.00M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 2230.00M | 2145.00M | 1656.00M | 820.00M | 692.00M |
Capital lease obligations | 215.00M | 219.00M | 225.00M | 231.00M | 197.00M |
Long term debt total | 2391.00M | 2392.00M | 2127.00M | 1237.00M | 1217.00M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -790.00000M | -1384.00000M | 427.00M | 2536.00M | 1191.00M |
Change to liabilities | 210.00M | 133.00M | 608.00M | -120.00000M | -130.00000M |
Total cashflows from investing activities | -790.00000M | -1653.00000M | -400.00000M | -293.00000M | 1143.00M |
Net borrowings | - | 17.00M | 886.00M | 558.00M | 623.00M |
Total cash from financing activities | -441.00000M | -183.00000M | 225.00M | -552.00000M | -1193.00000M |
Change to operating activities | -399.00000M | 1498.00M | 974.00M | -382.00000M | -794.00000M |
Net income | 792.00M | 659.00M | 673.00M | 737.00M | 707.00M |
Change in cash | -458.00000M | 283.00M | 1715.00M | -418.00000M | -364.00000M |
Begin period cash flow | 4506.00M | 4223.00M | 2508.00M | 2926.00M | 3290.00M |
End period cash flow | 4048.00M | 4506.00M | 4223.00M | 2508.00M | 2926.00M |
Total cash from operating activities | 773.00M | 2119.00M | 1890.00M | 427.00M | -314.00000M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 176.00M | 131.00M | 88.00M | 89.00M | 127.00M |
Other cashflows from investing activities | -699.00000M | -63.00000M | -753.00000M | 2.00M | -18.00000M |
Dividends paid | - | - | - | - | - |
Change to inventory | - | 415.00M | 100.00M | 76.00M | -794.00000M |
Change to account receivables | -95.00000M | -415.00000M | -100.00000M | -76.00000M | -530.00000M |
Sale purchase of stock | -454.00000M | -181.00000M | -606.00000M | -47.00000M | -549.00000M |
Other cashflows from financing activities | 13.00M | 721.00M | 1781.00M | -265.00000M | -531.00000M |
Change to netincome | 253.00M | 106.00M | 50.00M | 29.00M | 79.00M |
Capital expenditures | 91.00M | 77.00M | 74.00M | 57.00M | 30.00M |
Change receivables | -95.00000M | -415.00000M | -100.00000M | -76.00000M | -530.00000M |
Cash flows other operating | -563.00000M | 1047.00M | 571.00M | -232.00000M | -567.00000M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | -458.00000M | 283.00M | 1715.00M | -418.00000M | -364.00000M |
Change in working capital | -448.00000M | 1223.00M | 1064.00M | -433.00000M | -1249.00000M |
Stock based compensation | 103.00M | 72.00M | 57.00M | 39.00M | 27.00M |
Other non cash items | 216.00M | 58.00M | 27.00M | -15.00000M | 80.00M |
Free cash flow | 682.00M | 2042.00M | 1816.00M | 370.00M | -344.00000M |
Sector: Healthcare Industry: Healthcare Plans
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
MOH Molina Healthcare Inc |
1.23 0.36% | 346.23 | 22.32 | 15.15 | 0.63 | 5.29 | 0.40 | 8.59 |
UNH UnitedHealth Group Incorporated |
-18.81 3.14% | 580.66 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
ELV Elevance Health Inc |
-0.36 0.08% | 439.45 | 18.00 | 12.66 | 0.65 | 2.87 | 0.74 | |
CVS CVS Health Corp |
-0.28 0.40% | 69.23 | 12.06 | 9.08 | 0.29 | 1.34 | 0.47 | 8.96 |
CI Cigna Corp |
-2.32 0.70% | 327.87 | 30.25 | 10.09 | 0.39 | 2.10 | 0.50 |
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
200 Oceangate, Long Beach, CA, United States, 90802
Name | Title | Year Born |
---|---|---|
Mr. Joseph Michael Zubretsky | Pres, CEO & Director | 1957 |
Mr. Mark Lowell Keim | CFO & Treasurer | 1965 |
Mr. Jeffrey Don Barlow Esq., J.D., M.P.H. | Chief Legal Officer & Corp. Sec. | 1963 |
Mr. James Edwin Woys | Exec. VP of Health Plan Services | 1959 |
Mr. Marc Steven Russo | Exec. VP of Health Plans | 1970 |
Mr. Maurice Sebastian Hebert CPA | Chief Accounting Officer | 1963 |
Mr. Joseph F. Krocheski CFA | Sr. VP of Investor Relations | 1970 |
Ms. Joann Zarza-Garrido | VP of Compliance | NA |
Mr. Larry D. Anderson | Exec. VP & Chief HR Officer | NA |
Mr. David Jeffrey Pollack | Sr. VP of Health Plan Operations | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.